| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation. | J Exp Med | 2011 | 1.78 |
| 2 | The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation. | Oncologist | 2008 | 1.17 |
| 3 | Perceiving the avidity of T cell activation can be translated into peripheral T cell regulation. | Proc Natl Acad Sci U S A | 2007 | 1.16 |
| 4 | Herpes simplex virus oncolytic vaccine therapy in melanoma. | Expert Opin Biol Ther | 2010 | 0.86 |
| 5 | Melanoma immunotherapy. | Mt Sinai J Med | 2010 | 0.81 |
| 6 | Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013. | J Transl Med | 2014 | 0.80 |